Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1H | O95180 | 1/20 | 0.45 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.45 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 9/20 | 0.43 |
| ▸ | RAF1 | P04049 | 1/20 | 0.43 |
| ▸ | BRAF | P15056 | 1/20 | 0.43 |
| ▸ | BTK | Q06187 | 2/20 | 0.41 |
| ▸ | AAK1 | Q2M2I8 | 3/20 | 0.40 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.40 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.40 |
| ▸ | PPARG | P37231 | 2/20 | 0.39 |
| ▸ | KDM4A | O75164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30392478 | 0.91 | CACNA1H (0.45) | CACNA1HCACNA1BCACNA1CEPHX2RAF1 | |
| SCHEMBL26099209 | 0.91 | CACNA1H (0.45) | CACNA1HCACNA1BCACNA1CEPHX2RAF1 | |
| SCHEMBL26097041 | 0.86 | EPHX2 (0.46) | EPHX2BTKPPARG | |
| SCHEMBL15322811 | 0.78 | NAMPT (0.50) | KDM4A | |
| SCHEMBL12656366 | 0.77 | EPHX2 (0.46) | CACNA1HCACNA1BCACNA1CEPHX2RAF1 | |
| SCHEMBL16094537 | 0.77 | EPHX2 (0.46) | CACNA1HCACNA1BCACNA1CEPHX2RAF1 | |
| SCHEMBL26101623 | 0.76 | NTRK1 (0.44) | EPHX2PPARG | |
| SCHEMBL16794371 | 0.76 | AAK1 (0.62) | CACNA1HCACNA1BCACNA1CBTKAAK1 | |
| SCHEMBL24821267 | 0.75 | EPHX2 (0.44) | CACNA1HCACNA1BCACNA1CEPHX2RAF1 | |
| SCHEMBL28115513 | 0.75 | CACNA1H (0.51) | CACNA1HCACNA1BCACNA1CEPHX2RAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4704904-A1 | TETRAZINE-BASED TARGETING AGENTS FOR IN VIVO DELIVERY OF A PAYLOAD | Tambo, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| WO-2025059685-A1 | METHODS FOR IN VIVO TARGETED DELIVERY OF A PAYLOAD | TAMBO, INC. (US) | 2025-03-20 | — | — | WO | disclosed |
| WO-2024229427-A1 | TETRAZINE-BASED TARGETING AGENTS FOR IN VIVO DELIVERY OF A PAYLOAD | TAMBO, INC. (US) | 2024-11-07 | — | — | WO | disclosed |
| EP-4422696-A1 | TETRAZINE CONJUGATES FOR IN VIVO TARGETED DELIVERY OF A PAYLOAD | Tambo, Inc. (US) | 2024-09-04 | — | — | EP | disclosed |
| WO-2023077129-A1 | TETRAZINE CONJUGATES FOR IN VIVO TARGETED DELIVERY OF A PAYLOAD | TAMBO, INC. (US) | 2023-05-04 | — | — | WO | disclosed |
| WO-2023077129-A1 | TETRAZINE CONJUGATES FOR IN VIVO TARGETED DELIVERY OF A PAYLOAD | TAMBO, INC. (US) | 2023-05-04 | — | — | WO | disclosed |